Hydroxamic acids as pharmacological agents

Current Medicinal Chemistry

Volumn 9, Issue 17, 2002, Pages 1631-1653

  Muri, E M F ^a   Nieto, M J ^a   Sindelar, R D ^a   Williamson, J S ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Cyclooxygenases; Hydroxamic acids; Leukotriene A4 hydrolases; Lipoxigenases; Metalloenzyme inhibitors; Peptide deformilases; Zinc metalloproteinases

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; ACTINONIN; AE 941; ATRELEUTON; BATIMASTAT; CAPTOPRIL; CGS 27023A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDROLASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE; IDRAPRIL; LEUKOTRIENE A4 HYDROLASE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MARIMASTAT; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; N1 (1 CARBAMOYL 2,2 DIMETHYLPROPYL) 2 [3 (4 CHLOROPHENYL)PROPYL] N4 HYDROXYBUTANEDIAMIDE; PEPTIDE DEFORMYLASE INHIBITOR; PRINOMASTAT; PROSTAGLANDIN SYNTHASE; REBIMASTAT; TEPOXALIN; UNINDEXED DRUG; UREASE; UREASE INHIBITOR; ZILEUTON; ZINC; AMIDASE; AMINOPEPTIDASE; ENZYME INHIBITOR; EPOXIDE HYDROLASE; HYDROXAMIC ACID; PEPTIDE DEFORMYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ASTHMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DESIGN; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; HYPERTENSION; IC 50; LIVER TOXICITY; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM;

AMIDOHYDROLASES; AMINOPEPTIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENZYME INHIBITORS; EPOXIDE HYDROLASES; HUMANS; HYDROXAMIC ACIDS; INHIBITORY CONCENTRATION 50; METALLOENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035993854     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867023369402     Document Type: Review

References (157)

1. Bioactive Molecules